Company news
Beyond Air, Inc. news in 2021
Beyond Air, Inc.'s news releases, calls and decks from 2021, newest first.
Beyond Air® Provides Regulatory Update for LungFit® PH
December 8, 2021
Beyond Air® Expands Leadership Team with the Appointment of Dr. Andrew Colin to Chief Medical Officer
November 30, 2021
Beyond Air® Announces $30 Million of Committed Capital in Previously Reported Beyond Cancer™ Private Placement
November 17, 2021
Beyond Air® Reports Financial Results for the Second Quarter of Fiscal Year 2022
November 10, 2021
Beyond Air® Announces Formation of Beyond Cancer™, a New Private Company Dedicated to Oncology Utilizing Ultra-High Concentration Nitric Oxide to Treat Solid Tumors
November 3, 2021
Beyond Air® Schedules Second Fiscal Quarter 2022 Financial Results Conference Call and Webcast
October 24, 2021
Beyond Air® Reports Positive Interim Results for LungFit® GO Pilot Study Using High Concentration Inhaled Nitric Oxide Self-Administered, At-Home for Nontuberculous Mycobacterial Lung Disease
October 19, 2021
Beyond Air® Provides Global Regulatory Update for LungFit® PH
September 20, 2021
Beyond Air® Announces CFO Transition
August 19, 2021
Beyond Air® Reports Financial Results for the First Quarter of Fiscal Year 2022
August 9, 2021
Beyond Air® Schedules First Fiscal Quarter 2022 Financial Results Conference Call and Webcast
July 19, 2021
Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in July 2021
July 7, 2021
Beyond Air® Reports Financial Results for Fourth Fiscal Quarter and Year-End 2021
June 9, 2021
Beyond Air® Reaches Settlement Agreement with Circassia for LungFit® PH
May 25, 2021
Beyond Air® Schedules Fiscal Year 2021 Financial Results Conference Call and Webcast
May 24, 2021
Beyond Air® Strengthens Commercial Leadership Team with Appointments of Head of Sales and Head of Marketing
May 19, 2021
Beyond Air® Presents Data in Hospitalized Patients with Viral Lung Infections (including COVID-19) from LungFit® PRO Programs at ATS 2021
May 12, 2021
Beyond Air® Appoints Peter Senior as Director of Business Development
May 2, 2021
Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in May 2021
April 13, 2021
Beyond Air® to Present Abstracts at the American Thoracic Society Virtual Sessions in May 2021
March 23, 2021
Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in March 2021
February 28, 2021
Beyond Air® Receives Grant for Up to $2.17 million from the Cystic Fibrosis Foundation to Advance the Clinical Development of Inhaled Nitric Oxide to Treat Nontuberculous Mycobacteria Pulmonary Disease
February 15, 2021
Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Business Update
February 8, 2021
Beyond Air® Schedules Third Fiscal Quarter 2021 Financial Results Conference Call and Webcast
January 14, 2021